<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>q-bio.MN updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/q-bio.MN</link>
    <description>q-bio.MN updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/q-bio.MN" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Thu, 24 Oct 2024 02:08:39 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Wed, 23 Oct 2024 00:00:00 -0400</pubDate>
    <skipDays>
      <day>Sunday</day>
      <day>Saturday</day>
    </skipDays>
    <item>
      <title>Bacterial Pathogenicity Regulation by RNA-binding Antiterminators</title>
      <link>https://arxiv.org/abs/2410.16752</link>
      <description>arXiv:2410.16752v1 Announce Type: new 
Abstract: Antiterminators are essential components of bacterial transcriptional regulation, allowing the control of gene expression in response to fluctuating environmental conditions. RNA-binding antiterminators are particularly important regulatory proteins that play a significant role in preventing transcription termination by binding to specific RNA sequences. These RNA-binding antiterminators have been extensively studied for their roles in regulating various metabolic pathways. However, their role in modulating the physiology of pathogens requires further investigations. This review focuses on these RNA-binding proteins in both Gram-positive and Gram-negative bacteria, particularly on their structures, mechanism of action, and target genes. Additionally, the involvement of the antitermination mechanisms in bacterial pathogenicity will be discussed. This knowledge is crucial for understanding the regulatory mechanisms that govern bacterial pathogenicity, opening up exciting prospects for future research, and potentially new alternative strategies to fight against infectious diseases.</description>
      <guid isPermaLink="false">oai:arXiv.org:2410.16752v1</guid>
      <category>q-bio.MN</category>
      <pubDate>Wed, 23 Oct 2024 00:00:00 -0400</pubDate>
      <arxiv:announce_type>new</arxiv:announce_type>
      <dc:rights>http://arxiv.org/licenses/nonexclusive-distrib/1.0/</dc:rights>
      <dc:creator>Diane Soussan (CBSA), Ali Tahrioui (LMSM, CBSA), R R de la Haba (CBSA), Adrien Forge (CBSA), Sylvie Chevalier (LMSM, CBSA), Olivier Lesouhaitier (CBSA), C\'ecile Muller (CBSA)</dc:creator>
    </item>
  </channel>
</rss>
